Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the DMD Gene
Open Access
Abstract
Pseudoexon (PE) inclusion has been implicated in various dystrophinopathies; however, its splicing characteristics have not been fully investigated. This study aims to analyze the splicing characteristics of dystrophin PEs and compare them with those of dystrophin canonical exons (CEs). Forty-two reported dystrophin PEs were divided into a splice site (ss) group and a splicing regulatory element (SRE) group. Five dystrophin PEs with characteristics of poison exons were identified and categorized as the possible poison exon group. The comparative analysis of each essential splicing signal among different groups of dystrophin PEs and dystrophin CEs revealed that the possible poison exon group had a stronger 3′ ss compared to any other group. As for auxiliary SREs, different groups of dystrophin PEs were found to have a smaller density of diverse types of exonic splicing enhancers and a higher density of several types of exonic splicing silencers compared to dystrophin CEs. In addition, the possible poison exon group had a smaller density of 3′ ss intronic splicing silencers compared to dystrophin CEs. To our knowledge, our findings indicate for the first time that poison exons might exist in DMD (the dystrophin gene) and present with different splicing characteristics than other dystrophin PEs and CEs.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2016YFC1300605)
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z191100006619034)
This publication has 37 references indexed in Scilit:
- Cryptic exon activation causes dystrophinopathy in two Chinese familiesEuropean Journal of Human Genetics, 2020
- Pseudoexons of the DMD GeneJournal of Neuromuscular Diseases, 2020
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy MutationsHuman Mutation, 2015
- The human splicing code reveals new insights into the genetic determinants of diseaseScience, 2015
- Interplay between DMD Point Mutations and Splicing Signals in Dystrophinopathy PhenotypesPLOS ONE, 2013
- Genome-Wide Association between Branch Point Properties and Alternative SplicingPLOS Computational Biology, 2010
- RNA landscape of evolution for optimal exon and intron discriminationProceedings of the National Academy of Sciences, 2008
- DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapyAnnals of Neurology, 2007
- Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exonsJournal of Human Genetics, 2007
- Dystrophin and mutations: one gene, several proteins, multiple phenotypesThe Lancet Neurology, 2003